Sarepta Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$16.88

+0.10 (+0.60%)

As of Aug 8, 1:35 AM ET ·

Analyst Consensus

Hold

Analysts

Very High

Coverage

Buy 13 38%

Hold 15 44%

Sell 6 18%

Price Target

Analyst Price Target +135.8% upside

Low Target $34.71

Average Target $39.80

High Target $61.57

Current Price $16.88

Current
$16.88

Target
$39.80

$34.71 $39.80 avg $61.57

Scenario Analysis

Bear Case

$34.71

105.6%

Low target

Base Case

$39.80

+135.8%

Avg target

Bull Case

$61.57

+264.8%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$25.32

-33.3% from high

52-Week Low

$14.68

+15.0% from low

Target vs 52W High

$39.80

+57.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%